Immunocytochemical focus assay for potency determination of measles-mumps-rubella trivalent vaccine.
The immunocytochemically stained focus assay for the determination of potency of individual components in measles-mumps-rubella trivalent vaccine is described. The method involves the reaction of infected cultures maintained under the agar overlay medium sequentially with rabbit antiserum specific to each component, biotinylated anti-rabbit IgG serum, avidin-biotinylated-peroxidase complex, and substrate mixture. The potency of one component determined by the method was not influenced by the presence of two other components and was comparable to that determined by either dilution end point titration or plaque assay. The method offers a number of advantages over the current method based on neutralization of components other than the one to be titrated.
D000914:Antibodies, Viral / Q000276:immunology; D004338:Drug Combinations / Q000592:standards; D007124:Immunoenzyme Techniques; D007201:Indicator Dilution Techniques; D008458:Measles Vaccine / Q000592:standards*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000592:standards*; D012411:Rubella Vaccine / Q000592:standards*; D013194:Staining and Labeling; D014613:Vaccines, Attenuated / Q000592:standards*; D010948:Viral Plaque Assay
D000914:Antibodies, Viral; D004338:Drug Combinations; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D014613:Vaccines, Attenuated